Neoleukin Therapeutics
Why Robinhood?
You can watch NLTX and buy or sell other stocks, ETFs, and their options commission-free!About NLTX
Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.
NLTX Key Statistics
Stock Snapshot
With a market cap of 469.88M, Neoleukin Therapeutics(NLTX) trades at $30.09. The stock has a price-to-earnings ratio of -7.90.
Neoleukin Therapeutics(NLTX) stock opened on 2026-08-07 at —. The price climbed to — and dipped to —.
Neoleukin Therapeutics(NLTX) shares are trading with a volume of 0, against a daily average of 438.97K.
In the last year, Neoleukin Therapeutics(NLTX) shares hit a 52-week high of $43.66 and a 52-week low of $15.93.
In the last year, Neoleukin Therapeutics(NLTX) shares hit a 52-week high of $43.66 and a 52-week low of $15.93.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.